Search by Drug Name or NDC
NDC 68462-0469-54 Bumetanide 0.25 mg/mL Details
Bumetanide 0.25 mg/mL
Bumetanide is a INTRAMUSCULAR; INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by GLENMARK PHARMACEUTICALS INC., USA. The primary component is BUMETANIDE.
Product Information
| NDC | 68462-0469 |
|---|---|
| Product ID | 68462-469_680563fe-5d3a-49bc-86a5-740bda2acebe |
| Associated GPIs | |
| GCN Sequence Number | 008220 |
| GCN Sequence Number Description | bumetanide VIAL 0.25 MG/ML INJECTION |
| HIC3 | R1M |
| HIC3 Description | LOOP DIURETICS |
| GCN | 34810 |
| HICL Sequence Number | 003664 |
| HICL Sequence Number Description | BUMETANIDE |
| Brand/Generic | Generic |
| Proprietary Name | Bumetanide |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Bumetanide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 0.25 |
| Active Ingredient Units | mg/mL |
| Substance Name | BUMETANIDE |
| Labeler Name | GLENMARK PHARMACEUTICALS INC., USA |
| Pharmaceutical Class | Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA216434 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 68462-0469-54 (68462046954)
| NDC Package Code | 68462-469-54 |
|---|---|
| Billing NDC | 68462046954 |
| Package | 10 VIAL, SINGLE-DOSE in 1 CARTON (68462-469-54) / 4 mL in 1 VIAL, SINGLE-DOSE (68462-469-40) |
| Marketing Start Date | 2023-01-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |